SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-179674
Filing Date
2024-07-16
Accepted
2024-07-16 16:21:05
Documents
15
Period of Report
2024-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d867483d8k.htm   iXBRL 8-K 32913
2 EX-10.1 d867483dex101.htm EX-10.1 19812
  Complete submission text file 0001193125-24-179674.txt   243685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240711.xsd EX-101.SCH 5110
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240711_def.xml EX-101.DEF 15338
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240711_lab.xml EX-101.LAB 26238
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240711_pre.xml EX-101.PRE 16502
17 EXTRACTED XBRL INSTANCE DOCUMENT d867483d8k_htm.xml XML 9205
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241119883
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)